Inventor · disambiguated record
Milind Rajopadhye
Also filed as: RAJOPADHYE MILIND
43 granted patents·6 pending applications·779 citations·filing 1994–2017
98Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO21VISEN MEDICAL INC7DU PONT PHARM CO4RAJOPADHYE MILIND4DU PONT MERCK PHARMA2
Top patents by PatentIndex Score
49 records- 0196US8815214B2Fluorescent imaging agentsRAJOPADHYE MILIND·Filed 2009·Granted Aug 26, 2014·31 cites·15 claims
- 0296US7947256B2Biocompatible fluorescent imaging agentsVISEN MEDICAL INC·Filed 2006·Granted May 24, 2011·29 cites·15 claims
- 0395US8455651B2Nicotinic acid and picolinic acid derived near-infrared fluorophoresRAJOPADHYE MILIND·Filed 2012·Granted Jun 4, 2013·15 cites·16 claims
- 0495US6537520B1Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 25, 2003·91 cites·37 claims
- 0594US8173819B2Nicotinic and picolinic acid derived near-infrared fluorophoresRAJOPADHYE MILIND·Filed 2006·Granted May 8, 2012·23 cites·20 claims
- 0693US9999687B2Fluorescent imaging agentsVISEN MEDICAL INC·Filed 2016·Granted Jun 19, 2018·9 cites·13 claims
- 0793US8771646B2Nicotinic acid and picolinic acid derived near-infrared fluorophoresVISEN MEDICAL INC·Filed 2013·Granted Jul 8, 2014·14 cites·27 claims
- 0893US6800273B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 5, 2004·46 cites·25 claims
- 0992US9913917B2Biocompatible fluorescent metal oxide nanoparticlesGROVES KEVIN·Filed 2006·Granted Mar 13, 2018·15 cites·36 claims
- 1091US8685370B2Integrin targeting agents and in-vivo and in-vitro imaging methods using the sameRAJOPADHYE MILIND·Filed 2009·Granted Apr 1, 2014·22 cites·46 claims
- 1191US6656448B1Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 2, 2003·31 cites·17 claims
- 1291US6569402B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 27, 2003·24 cites·28 claims
- 1390US9427481B2Fluorescent imaging agentsVISEN MEDICAL INC·Filed 2014·Granted Aug 30, 2016·6 cites·20 claims
- 1490US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 1589US5750088AStable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticalsDU PONT MERCK PHARMA·Filed 1995·Granted May 12, 1998·49 cites·7 claims
- 1686US6511649B1Vitronectin receptor antagonist pharmaceuticalsFiled 2000·Granted Jan 28, 2003·19 cites·46 claims
- 1785US6322770B1Indazole vitronectin receptor antagonist pharmaceuticalsDU PONT PHARM CO·Filed 1999·Granted Nov 27, 2001·69 cites·70 claims
- 1883US10092188B2Methods and compositions for identifying subjects at risk of developing stent thrombosisVISEN MEDICAL INC·Filed 2014·Granted Oct 9, 2018·14 cites·13 claims
- 1983US6818201B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 16, 2004·7 cites·55 claims
- 2082US9574085B2Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labelsNARAYANAN NARASIMHACHARI·Filed 2006·Granted Feb 21, 2017·4 cites·15 claims
- 2181US9694089B2Integrin targeting agents and in-vivo and in-vitro imaging methods using the sameVISEN MEDICAL INC·Filed 2014·Granted Jul 4, 2017·5 cites·59 claims
- 2281US6511648B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Jan 28, 2003·35 cites·125 claims
- 2380US7332149B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Feb 19, 2008·8 cites·5 claims
- 2480US6416733B1Radiopharmaceuticals for imaging infection and inflammationBRISTOL MYERS SQUIBB PHARMA CO·Filed 1997·Granted Jul 9, 2002·56 cites·11 claims
- 2579US7321045B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 22, 2008·4 cites·1 claims
- 2678US7052673B2Pharmaceuticals for the imaging of angiogenic disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 30, 2006·8 cites·22 claims
- 2777US6683163B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 27, 2004·6 cites·8 claims
- 2874US8864821B2Methods and compositions for identifying subjects at risk of developing stent thrombosisJAFFER FAROUC·Filed 2009·Granted Oct 21, 2014·14 cites·6 claims
- 2972US7060248B2Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 13, 2006·2 cites·53 claims
- 3072US6818659B2(2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptidesBRISTOL MYERS SQUIBB PHARMA IN·Filed 2001·Granted Nov 16, 2004·4 cites·15 claims
- 3171US6989139B2Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 24, 2006·5 cites·24 claims
- 3271US6743412B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 1, 2004·3 cites·12 claims
- 3368US6689337B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Feb 10, 2004·2 cites·4 claims
- 3460US10442930B2Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labelsVISEN MEDICAL INC·Filed 2017·Granted Oct 15, 2019·0 cites·9 claims
- 3559US7018611B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 28, 2006·0 cites·26 claims
- 3659US5879657ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT MERCK PHARMA·Filed 1994·Granted Mar 9, 1999·23 cites·70 claims
- 3755US6558649B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted May 6, 2003·6 cites·9 claims
- 3854US2003007927A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
- 3954US2005287074A1Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Application pending·0 cites
- 4053US6524554B1Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancerBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Feb 25, 2003·12 cites·22 claims
- 4151US7090828B2Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Aug 15, 2006·0 cites·14 claims
- 4249US6015904AStable reagents for the preparation of radio pharmaceuticalsFiled 1997·Granted Jan 18, 2000·11 cites·11 claims
- 4348US2003152512A1Imaging thrombus with glycoprotein llb/llla antagonistsFiled 2001·Application pending·0 cites
- 4445US2010172841A1Viable near-infrared fluorochrome labeled cells and methods of making and using the samePETERSON JEFFREY D·Filed 2009·Application pending·0 cites
- 4544US2008102036A1Biocompatible Fluorescent Silicon NanoparticlesPOSS KIRTLAND G·Filed 2004·Application pending·0 cites
- 4642US5888970ATechnetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agentsDU PONT PHARM CO·Filed 1997·Granted Mar 30, 1999·3 cites·19 claims
- 4741US6794518B1Vitronectin receptor antagonist pharmaceuticalsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 21, 2004·2 cites·3 claims
- 4839US5961952A99m Tc-tertiary-butyl isonitrile as breast tumor imaging agentsDU PONT PHARM CO·Filed 1997·Granted Oct 5, 1999·6 cites·40 claims
- 4937US2003124053A1Radiopharmaceuticals for imaging infection and inflammationFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →